A surgeon's eyes were exposed to a patient's blood with a high hepatitis C virus (HCV) RNA level (~7 log). What is the recommended post‑exposure prophylaxis and management plan?

Management of Occupational HCV Exposure via Mucous Membrane (Eye Splash)

No post-exposure prophylaxis is recommended for HCV, but immediate decontamination and a structured testing protocol should be implemented to enable early diagnosis and treatment if infection occurs 1, 2.

Immediate Actions (Within Minutes)

• Flush the exposed eyes thoroughly with water or saline immediately 1
• Document the exposure details and the high viral load (7 log HCV RNA) of the source patient

Testing Protocol for the Exposed Surgeon

Baseline Testing (Within 48 Hours)

• Anti-HCV antibody with reflex to HCV RNA if positive 2
• Alanine aminotransferase (ALT) 1

This baseline establishes whether the surgeon had pre-existing HCV infection.

Follow-Up Testing Timeline

At 3-6 weeks post-exposure:

• HCV RNA by nucleic acid test (NAT) - this is the critical early detection test 2
• This allows for early diagnosis if transmission occurred, which is particularly important given the high viral load of the source

At 4-6 months post-exposure:

• Anti-HCV antibody (final test if HCV RNA was negative at 3-6 weeks) 1, 2
• ALT 1

Why No Prophylaxis?

There is no effective post-exposure prophylaxis for HCV 1. The evidence is clear on this point across all major guidelines. A pilot study examining peginterferon alfa-2b as prophylaxis showed it was safe but provided no evidence of benefit, as transmission rates were extremely low regardless of treatment 3.

Critical Counseling Points

• Advise the surgeon to seek immediate medical evaluation if any acute illness develops during the follow-up period 1
• The risk of HCV transmission from mucous membrane exposure to blood is low but not zero - estimated at 0.2-10% for needlestick injuries, likely lower for mucous membrane exposure 3
• If HCV RNA becomes positive at any point, immediate referral for treatment is indicated 2, 4
  • Modern direct-acting antivirals achieve >95% cure rates and treatment during acute infection may prevent chronification 4, 5

Common Pitfall to Avoid

Do not skip the 3-6 week HCV RNA test. While the 4-6 month anti-HCV test will eventually detect infection, the earlier RNA test at 3-6 weeks allows for early treatment during the acute phase, which can prevent chronic infection from developing 2, 4. Given the source patient's high viral load (7 log), early detection is particularly valuable.

Additional Considerations

• Verify the surgeon's hepatitis B immunity status and provide post-exposure prophylaxis if needed (separate from HCV management) 1
• Consider HIV testing and prophylaxis based on source patient risk factors, though this is typically not indicated unless specific risk factors are present 1